Bilal Arif Sarepta Therapeutics, Inc. (SRPT) insider trading activity

Bilal Arif is Chief Tech Ops Officer of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 24,747 shares of SRPT, which is worth approximately $2.47 Million. The most recent transaction as insider was on Mar 07, 2025, when has been sold 9,035 shares (Common Stock) at a price of $103.7 per share, resulting in proceeds of $936,929. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.7K

42.53% 3M change

1.88% 12M change

Total Value Held $2.47 Million

Bilal Arif Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2025	SELL Payment of exercise price or tax liability	$936,929 $103.7 p/Share	9,035 Reduced 26.75%	24,747 Common Stock
Mar 06 2025	BUY Exercise of conversion of derivative security	-	17,500 Added 34.13%	33,782 Common Stock
Mar 04 2025	SELL Payment of exercise price or tax liability	$52,088 $101.34 p/Share	514 Reduced 3.06%	16,282 Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$74,610 $103.77 p/Share	719 Reduced 4.11%	16,796 Common Stock
Jun 25 2024	SELL Open market or private sale	$636,270 $163.23 p/Share	3,898 Reduced 18.33%	17,363 Common Stock
Jun 24 2024	SELL Payment of exercise price or tax liability	$387,233 $164.64 p/Share	2,352 Reduced 7.47%	29,120 Common Stock
Jun 24 2024	SELL Open market or private sale	$1,295,163 $164.8 p/Share	7,859 Reduced 26.99%	21,261 Common Stock
Jun 21 2024	BUY Exercise of conversion of derivative security	-	6,250 Added 16.57%	31,472 Common Stock
Mar 08 2024	SELL Payment of exercise price or tax liability	$58,122 $123.14 p/Share	472 Reduced 1.84%	25,222 Common Stock
Mar 07 2024	SELL Payment of exercise price or tax liability	$60,967 $120.49 p/Share	506 Reduced 1.93%	25,694 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$65,417 $125.32 p/Share	522 Reduced 1.95%	26,200 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$46,059 $126.19 p/Share	365 Reduced 1.35%	26,722 Common Stock
Mar 01 2024	SELL Open market or private sale	$258,300 $129.15 p/Share	2,000 Reduced 6.94%	26,836 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	6,000 Added 17.22%	28,836 Common Stock
Dec 01 2023	SELL Payment of exercise price or tax liability	$295,811 $80.34 p/Share	3,682 Reduced 13.86%	22,886 Common Stock
Mar 30 2023	SELL Payment of exercise price or tax liability	$41,954 $136.66 p/Share	307 Reduced 1.15%	26,367 Common Stock
Mar 08 2023	SELL Payment of exercise price or tax liability	$48,101 $153.19 p/Share	314 Reduced 1.16%	26,674 Common Stock
Mar 06 2023	SELL Payment of exercise price or tax liability	$53,451 $157.21 p/Share	340 Reduced 1.49%	22,488 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	4,500 Added 14.29%	26,988 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$37,187 $147.57 p/Share	252 Reduced 1.09%	22,828 Common Stock

Bilal Arif

Chief Tech Ops Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Value

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Sarepta Therapeutics, Inc.

Track Activities on SRPT

Account